Loading insider details...
Beta
Latest Form 4 (Oct 19, 2026): Sale of 34,294 XGN shares, $269.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 19, 2026 | EXAGEN INC. (XGN) | Sale | 34,294 | $269.8K |
| Mar 16, 2026 | EXAGEN INC. (XGN) | Grant/Award | 150,000 | n/a |
| Mar 4, 2026 | EXAGEN INC. (XGN) | Sale | 15,698 | $56.8K |
| Feb 26, 2026 | EXAGEN INC. (XGN) | Sale | 11,430 | $41.3K |
| Oct 20, 2025 | EXAGEN INC. (XGN) | Sale | 31,787 | $375.6K |
| Mar 4, 2025 | EXAGEN INC. (XGN) | Grant/Award | 8,621 | $21.3K |
| Feb 26, 2025 | EXAGEN INC. (XGN) | Grant/Award | 112,500 | n/a |
| Nov 18, 2024 | EXAGEN INC. (XGN) | Purchase | 24,305 | $68.3K |
| May 17, 2024 | EXAGEN INC. (XGN) | Purchase | 40,401 | $77.6K |
| Mar 4, 2024 | EXAGEN INC. (XGN) | Grant/Award | 9,804 | $18.7K |